Table 2.

Three- and five-year relative survival rates of cutaneous verrucous carcinoma (CVC) patients by age group (2000–2019), and projected rates for survival rates (2020–2024).

Age groups (year)	2000–2004	2005–2009	2010–2014	2015–2019	2020–2024
3-year survival rates
15–44 years	94.5 ± 0.039	96.2 ± 0.043	100 ± 0.000	86.2 ± 0.096	93.318
45–54 year	87.2 ± 0.048	85.2 ± 0.045	96.3 ± 0.029	78.5 ± 0.045	82.285
55–64 year	92.0 ± 0.034	89.3 ± 0.035	92.8 ± 0.029	89.3 ± 0.038	90.180
65–74 year	92.3 ± 0.037	88.7 ± 0.044	86.3 ± 0.043	91.1 ± 0.043	89.095
75+ year	85.1 ± 0.050	80.2 ± 0.056	84.9 ± 0.046	72.5 ± 0.064	73.960
5-year survival rates
15–44 years	92.2 ± 0.048	92.4 ± 0.059	100 ± 0.000	86.2 ± 0.096	93.169
45–54 year	85.9 ± 0.050	82.8 ± 0.049	96.3 ± 0.029	74.9 ± 0.067	80.555
55–64 year	89.6 ± 0.040	85.8 ± 0.042	88.4 ± 0.046	88.4 ± 0.046	87.401
65–74 year	84.0 ± 0.051	95.1 ± 0.026	80.5 ± 0.052	88.9 ± 0.059	86.634
75+ year	74.7 ± 0.065	73.4 ± 0.069	78.4 ± 0.067	65.9 ± 0.130	67.016

Data are means ± standard error of the means.